Medical Care

Global Adjuvant Therapy Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Adjuvant Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adjuvant Therapy.
The Adjuvant Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adjuvant Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adjuvant Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Bayer
Johnson & Johnson
AstraZenca
Mylan
AbbVie
Novartis
Segment by Type
Chemotherapy
Radiotherapy
Hormonotherapy
Others
Segment by Application
Hospital
Medical Institution
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adjuvant Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adjuvant Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Hormonotherapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Adjuvant Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Institution
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adjuvant Therapy Market Perspective (2020-2031)
2.2 Global Adjuvant Therapy Growth Trends by Region
2.2.1 Global Adjuvant Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Adjuvant Therapy Historic Market Size by Region (2020-2025)
2.2.3 Adjuvant Therapy Forecasted Market Size by Region (2026-2031)
2.3 Adjuvant Therapy Market Dynamics
2.3.1 Adjuvant Therapy Industry Trends
2.3.2 Adjuvant Therapy Market Drivers
2.3.3 Adjuvant Therapy Market Challenges
2.3.4 Adjuvant Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adjuvant Therapy Players by Revenue
3.1.1 Global Top Adjuvant Therapy Players by Revenue (2020-2025)
3.1.2 Global Adjuvant Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Adjuvant Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Adjuvant Therapy Revenue
3.4 Global Adjuvant Therapy Market Concentration Ratio
3.4.1 Global Adjuvant Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adjuvant Therapy Revenue in 2024
3.5 Global Key Players of Adjuvant Therapy Head office and Area Served
3.6 Global Key Players of Adjuvant Therapy, Product and Application
3.7 Global Key Players of Adjuvant Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Adjuvant Therapy Breakdown Data by Type
4.1 Global Adjuvant Therapy Historic Market Size by Type (2020-2025)
4.2 Global Adjuvant Therapy Forecasted Market Size by Type (2026-2031)
5 Adjuvant Therapy Breakdown Data by Application
5.1 Global Adjuvant Therapy Historic Market Size by Application (2020-2025)
5.2 Global Adjuvant Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Adjuvant Therapy Market Size (2020-2031)
6.2 North America Adjuvant Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Adjuvant Therapy Market Size by Country (2020-2025)
6.4 North America Adjuvant Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adjuvant Therapy Market Size (2020-2031)
7.2 Europe Adjuvant Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Adjuvant Therapy Market Size by Country (2020-2025)
7.4 Europe Adjuvant Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adjuvant Therapy Market Size (2020-2031)
8.2 Asia-Pacific Adjuvant Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Adjuvant Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Adjuvant Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adjuvant Therapy Market Size (2020-2031)
9.2 Latin America Adjuvant Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Adjuvant Therapy Market Size by Country (2020-2025)
9.4 Latin America Adjuvant Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adjuvant Therapy Market Size (2020-2031)
10.2 Middle East & Africa Adjuvant Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Adjuvant Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Adjuvant Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Adjuvant Therapy Introduction
11.1.4 Merck Revenue in Adjuvant Therapy Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Adjuvant Therapy Introduction
11.2.4 Bayer Revenue in Adjuvant Therapy Business (2020-2025)
11.2.5 Bayer Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Adjuvant Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Adjuvant Therapy Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 AstraZenca
11.4.1 AstraZenca Company Details
11.4.2 AstraZenca Business Overview
11.4.3 AstraZenca Adjuvant Therapy Introduction
11.4.4 AstraZenca Revenue in Adjuvant Therapy Business (2020-2025)
11.4.5 AstraZenca Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Adjuvant Therapy Introduction
11.5.4 Mylan Revenue in Adjuvant Therapy Business (2020-2025)
11.5.5 Mylan Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Adjuvant Therapy Introduction
11.6.4 AbbVie Revenue in Adjuvant Therapy Business (2020-2025)
11.6.5 AbbVie Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Adjuvant Therapy Introduction
11.7.4 Novartis Revenue in Adjuvant Therapy Business (2020-2025)
11.7.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Adjuvant Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Hormonotherapy
Table 5. Key Players of Others
Table 6. Global Adjuvant Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Adjuvant Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Adjuvant Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Adjuvant Therapy Market Share by Region (2020-2025)
Table 10. Global Adjuvant Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Adjuvant Therapy Market Share by Region (2026-2031)
Table 12. Adjuvant Therapy Market Trends
Table 13. Adjuvant Therapy Market Drivers
Table 14. Adjuvant Therapy Market Challenges
Table 15. Adjuvant Therapy Market Restraints
Table 16. Global Adjuvant Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Adjuvant Therapy Market Share by Players (2020-2025)
Table 18. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvant Therapy as of 2024)
Table 19. Ranking of Global Top Adjuvant Therapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Adjuvant Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Adjuvant Therapy, Headquarters and Area Served
Table 22. Global Key Players of Adjuvant Therapy, Product and Application
Table 23. Global Key Players of Adjuvant Therapy, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adjuvant Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Adjuvant Therapy Revenue Market Share by Type (2020-2025)
Table 27. Global Adjuvant Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Adjuvant Therapy Revenue Market Share by Type (2026-2031)
Table 29. Global Adjuvant Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Adjuvant Therapy Revenue Market Share by Application (2020-2025)
Table 31. Global Adjuvant Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Adjuvant Therapy Revenue Market Share by Application (2026-2031)
Table 33. North America Adjuvant Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Adjuvant Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Adjuvant Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Adjuvant Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Adjuvant Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Adjuvant Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Adjuvant Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Adjuvant Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Adjuvant Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Adjuvant Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Adjuvant Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Adjuvant Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Adjuvant Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Adjuvant Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Adjuvant Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 48. Merck Company Details
Table 49. Merck Business Overview
Table 50. Merck Adjuvant Therapy Product
Table 51. Merck Revenue in Adjuvant Therapy Business (2020-2025) & (US$ Million)
Table 52. Merck Recent Development
Table 53. Bayer Company Details
Table 54. Bayer Business Overview
Table 55. Bayer Adjuvant Therapy Product
Table 56. Bayer Revenue in Adjuvant Therapy Business (2020-2025) & (US$ Million)
Table 57. Bayer Recent Development
Table 58. Johnson & Johnson Company Details
Table 59. Johnson & Johnson Business Overview
Table 60. Johnson & Johnson Adjuvant Therapy Product
Table 61. Johnson & Johnson Revenue in Adjuvant Therapy Business (2020-2025) & (US$ Million)
Table 62. Johnson & Johnson Recent Development
Table 63. AstraZenca Company Details
Table 64. AstraZenca Business Overview
Table 65. AstraZenca Adjuvant Therapy Product
Table 66. AstraZenca Revenue in Adjuvant Therapy Business (2020-2025) & (US$ Million)
Table 67. AstraZenca Recent Development
Table 68. Mylan Company Details
Table 69. Mylan Business Overview
Table 70. Mylan Adjuvant Therapy Product
Table 71. Mylan Revenue in Adjuvant Therapy Business (2020-2025) & (US$ Million)
Table 72. Mylan Recent Development
Table 73. AbbVie Company Details
Table 74. AbbVie Business Overview
Table 75. AbbVie Adjuvant Therapy Product
Table 76. AbbVie Revenue in Adjuvant Therapy Business (2020-2025) & (US$ Million)
Table 77. AbbVie Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Adjuvant Therapy Product
Table 81. Novartis Revenue in Adjuvant Therapy Business (2020-2025) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report


List of Figures
Figure 1. Adjuvant Therapy Picture
Figure 2. Global Adjuvant Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Adjuvant Therapy Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Radiotherapy Features
Figure 6. Hormonotherapy Features
Figure 7. Others Features
Figure 8. Global Adjuvant Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Adjuvant Therapy Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Medical Institution Case Studies
Figure 12. Others Case Studies
Figure 13. Adjuvant Therapy Report Years Considered
Figure 14. Global Adjuvant Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Adjuvant Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Adjuvant Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Adjuvant Therapy Market Share by Players in 2024
Figure 18. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvant Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Adjuvant Therapy Revenue in 2024
Figure 20. North America Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Adjuvant Therapy Market Share by Country (2020-2031)
Figure 22. United States Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Adjuvant Therapy Market Share by Country (2020-2031)
Figure 26. Germany Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Adjuvant Therapy Market Share by Region (2020-2031)
Figure 34. China Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Adjuvant Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Adjuvant Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Adjuvant Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Merck Revenue Growth Rate in Adjuvant Therapy Business (2020-2025)
Figure 50. Bayer Revenue Growth Rate in Adjuvant Therapy Business (2020-2025)
Figure 51. Johnson & Johnson Revenue Growth Rate in Adjuvant Therapy Business (2020-2025)
Figure 52. AstraZenca Revenue Growth Rate in Adjuvant Therapy Business (2020-2025)
Figure 53. Mylan Revenue Growth Rate in Adjuvant Therapy Business (2020-2025)
Figure 54. AbbVie Revenue Growth Rate in Adjuvant Therapy Business (2020-2025)
Figure 55. Novartis Revenue Growth Rate in Adjuvant Therapy Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies